2016-03-05T00:00:00.000-05:00
GTx,-0.201253
building lean body,0.265391
current price,0.702596
Ratings Network.com reports,-0.223722
email newsletter,0.615479
medical conditions,-0.108683
advanced breast cancer,-0.274641
GTx Inc.,0.615479
quarterly earnings results,-0.262873
Zacks Investment Research‘s,0.702596
email address,0.460978
related companies,0.615479
InvestorPlace Broker Center,0.555736
total value,0.338403
1-year high,-0.554602
high fees,-0.735674
biopharmaceutical company,0.318405
prostate cancer,-0.545481
lead candidate,0.222748
Zacks Investment Research,0.319748
personal trading style,0.598412
latest news,0.460978
target price,0.284844
research offerings,0.40995
average price,0.263631
estrogen receptor,-0.274641
shares,0.250184
consensus estimate,0.416804
small molecules,-0.400673
company’s stock,0.284844
concise daily summary,0.460978
stock broker,0.245696
price objective points,0.702596
potential upside,0.702596
negative breast cancer,-0.62991
